These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 26945359)

  • 21. MicroRNA-223 and microRNA-92a in stool and plasma samples act as complementary biomarkers to increase colorectal cancer detection.
    Chang PY; Chen CC; Chang YS; Tsai WS; You JF; Lin GP; Chen TW; Chen JS; Chan EC
    Oncotarget; 2016 Mar; 7(9):10663-75. PubMed ID: 26848774
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A plasma microRNA panel for early detection of colorectal cancer.
    Wang S; Xiang J; Li Z; Lu S; Hu J; Gao X; Yu L; Wang L; Wang J; Wu Y; Chen Z; Zhu H
    Int J Cancer; 2015 Jan; 136(1):152-61. PubMed ID: 23456911
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fecal Occult Blood Tests in Colorectal Cancer Screening: Systematic Review and Meta-analysis of Traditional and New-generation Fecal Immunochemical Tests.
    Meklin J; SyrjÄnen K; Eskelinen M
    Anticancer Res; 2020 Jul; 40(7):3591-3604. PubMed ID: 32620599
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of microRNAs as diagnostic biomarkers in screening of head and neck cancer: a meta-analysis.
    Zhang M; Zhao LJ; Liang WQ; Mao ZP
    Genet Mol Res; 2015 Dec; 14(4):16562-76. PubMed ID: 26681002
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical utilization of serum- or plasma-based miRNAs as early detection biomarkers for pancreatic cancer: A meta-analysis up to now.
    Wei L; Yao K; Gan S; Suo Z
    Medicine (Baltimore); 2018 Aug; 97(35):e12132. PubMed ID: 30170450
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The accuracy of circulating microRNA-21 in the diagnosis of colorectal cancer: a systematic review and meta-analysis.
    Xu F; Xu L; Wang M; An G; Feng G
    Colorectal Dis; 2015 May; 17(5):O100-7. PubMed ID: 25683351
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circulating microRNA-21 as a biomarker for the detection of various carcinomas: an updated meta-analysis based on 36 studies.
    Wu K; Li L; Li S
    Tumour Biol; 2015 Mar; 36(3):1973-81. PubMed ID: 25527152
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The potential of plasma miRNAs for diagnosis and risk estimation of colorectal cancer.
    Chen WY; Zhao XJ; Yu ZF; Hu FL; Liu YP; Cui BB; Dong XS; Zhao YS
    Int J Clin Exp Pathol; 2015; 8(6):7092-101. PubMed ID: 26261602
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Faecal microRNAs as a non-invasive tool in the diagnosis of colonic adenomas and colorectal cancer: A meta-analysis.
    Yau TO; Tang CM; Harriss EK; Dickins B; Polytarchou C
    Sci Rep; 2019 Jul; 9(1):9491. PubMed ID: 31263200
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of circulating microRNAs as biomarkers in diagnosis of hematologic cancers: a meta-analysis.
    Li Q; Liu L; Li W
    Tumour Biol; 2014 Oct; 35(10):10467-78. PubMed ID: 25053601
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinically relevant circulating microRNA profiling studies in pancreatic cancer using meta-analysis.
    Pei Z; Liu SM; Huang JT; Zhang X; Yan D; Xia Q; Ji C; Chen W; Zhang X; Xu J; Wang J
    Oncotarget; 2017 Apr; 8(14):22616-22624. PubMed ID: 28186984
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Value of Blood-Based microRNAs in the Diagnosis of Acute Myocardial Infarction: A Systematic Review and Meta-Analysis.
    Zhai C; Li R; Hou K; Chen J; Alzogool M; Hu Y; Zhang J; Zhang Y; Wang L; Zhang R; Cong H
    Front Physiol; 2020; 11():691. PubMed ID: 32922300
    [No Abstract]   [Full Text] [Related]  

  • 33. MicroRNAs as Biomarkers for the Diagnostics of Bladder Cancer: a Meta-Analysis.
    Chen L; Cui Z; Liu Y; Bai Y; Lan F
    Clin Lab; 2015; 61(8):1101-8. PubMed ID: 26427157
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnostic Accuracy of Fecal Immunochemical Test in Patients at Increased Risk for Colorectal Cancer: A Meta-analysis.
    Katsoula A; Paschos P; Haidich AB; Tsapas A; Giouleme O
    JAMA Intern Med; 2017 Aug; 177(8):1110-1118. PubMed ID: 28628706
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Insights into the potential use of microRNAs as a novel class of biomarkers in esophageal cancer.
    Wan J; Wu W; Che Y; Kang N; Zhang R
    Dis Esophagus; 2016 Jul; 29(5):412-20. PubMed ID: 25789723
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circulating microRNA-1290 as a novel diagnostic and prognostic biomarker in human colorectal cancer.
    Imaoka H; Toiyama Y; Fujikawa H; Hiro J; Saigusa S; Tanaka K; Inoue Y; Mohri Y; Mori T; Kato T; Toden S; Goel A; Kusunoki M
    Ann Oncol; 2016 Oct; 27(10):1879-86. PubMed ID: 27502702
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Circulating miRNAs as Novel Diagnostic Biomarkers in Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.
    Cai C; Lin Y; Yu C
    Can J Gastroenterol Hepatol; 2019; 2019():2096161. PubMed ID: 31531307
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnostic significance of circulating miRNAs in systemic lupus erythematosus.
    Zheng X; Zhang Y; Yue P; Liu L; Wang C; Zhou K; Hua Y; Wu G; Li Y
    PLoS One; 2019; 14(6):e0217523. PubMed ID: 31163082
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Extracellular vesicle biomarkers in circulation for colorectal cancer detection: a systematic review and meta-analysis.
    Shi X; Zhao X; Xue J; Jia E
    BMC Cancer; 2024 May; 24(1):623. PubMed ID: 38778252
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnostic performance of urine and blood microRNAs for bladder cancer: a meta-analysis.
    Ye Q; Wang J; Xu D; Liu Y; Zhang D; Ye J; Li H
    Expert Rev Anticancer Ther; 2022 Dec; 22(12):1357-1369. PubMed ID: 36374119
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.